Goddard GV, McIntyre DC, Leech CK:A permanent change in brain function resulting from daily electrical stimulation.Exp Neurol 1969,25:295–330.
Racine RJ:Modification of seizure activity by electrical stimulation. II. Motor seizure.Electroencephalogr Clin Neurophysiol 1972,32:281–294.
Racine RJ:Modification of seizure activity by electrical stimulation. I. After-discharge threshold.Electroencephalogr Clin Neurophysiol 1972,32:269–279.
Racine R:Kindling: the first decade.Neurosurgery 1978,3:234–252.
Pinel JP, Rovner LI:Experimental epileptogenesis: kindling-induced epilepsy in rats.Exp Neurol 1978,58:190–202.
Wada JA, Sato M, Corcoran ME:Persistent seizure susceptibility and recurrent spontaneous seizures in kindled cats.Epilepsia 1974,15:465–478.
Weiss SR, Post RM:Caveats in the use of the kindling model of affective disorders.Toxicol Ind Health 1994,10:421–447.
Post RM, Ketter TA, Speer AM,et al.:Predictive validity of the sensitization and kindling hypotheses. InBipolar Disorders: Basic Mechanisms and Therapeutic Implications. Edited by Soares JC, Gershon S. New York: Marcel Dekker; 2000:387–432.
Goddard GV, Douglas RM:Does the engram of kindling model the engram of normal long term memory?
Can J Neurol Sci 1975,2:385–394.
Post RM, Weiss SRB, Leverich GS,et al.:Sensitization and kindling-like phenomena in bipolar disorder: implications for psychopharmacology.Clin Neurosci Res 2001,1:69–81.
Pinel JPJ:Effects of diazepam and diphenylhydantoin on elicited and spontaneous seizures in kindled rats: a double dissociation.Pharmacol Biochem Behav 1983,18:61–63.
Post RM:Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms?
Epilepsy Res 2002,50:203–219.
Post RM, Weiss SR, Pert A:Differential effects of carbamazepine and lithium on sensitization and kindling.Prog Neuropsychopharmacol Biol Psychiatry 1984,8:425–434.
Post RM, Weiss SR, Pert A:Cocaine-induced behavioral sensitization and kindling: implications for the emergence of psychopathology and seizures.Ann N Y Acad Sci 1988,537:292–308.
Post RM, Weiss SR, Pert A:Implications of behavioral sensitization and kindling for stress- induced behavioral change.Adv Exp Med Biol 1988,245:441–463.
Weiss SR, Post RM, Pert A,et al.:Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression.Pharmacol Biochem Behav 1989,34:655–661.
Post RM, Weiss SR, Fontana D, Pert A:Conditioned sensitization to the psychomotor stimulant cocaine.Ann N Y Acad Sci 1992,654:386–399.
Weiss SR, Clark M, Rosen JB,et al.:Contingent tolerance to the anticonvulsant effects of carbamazepine: relationship to loss of endogenous adaptive mechanisms.Brain Res Brain Res Rev 1995,20:305–325.
Post RM, Weiss SRB:Kindling and stress sensitization. InBipolar Disorder: Biological Models and Their Clinical Application. Edited by Joffe RT, Young LT. New York: Marcel Dekker; 1997:93–126.
Childress AR, McLellan AT, Ehrman R, O’Brien CP:Classically conditioned responses in opioid and cocaine dependence: a role in relapse?
NIDA Res Monogr 1988,84:25–43.
O’Brien CP, Childress AR, McLellan AT, Ehrman R:Classical conditioning in drug-dependent humans.Ann N Y Acad Sci 1992,654:400–415.
Barnes SJ, Pinel JP:Conditioned effects of kindling.Neurosci Biobehav Rev 2001,25:745–751.
Kendler KS, Thornton LM, Gardner CO:Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis.Am J Psychiatry 2000,157:1243–1251.
Kendler KS, Thornton LM, Gardner CO:Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression.Am J Psychiatry 2001,158:582–586.
Caspi A, Sugden K, Moffitt TE,et al.:Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.Science 2003,301:386–389.
Leverich GS, McElroy SL, Suppes T,et al.:Early physical and sexual abuse associated with an adverse course of bipolar illness.Biol Psychiatry 2002,51:288–297.
Hammen C, Gitlin M:Stress reactivity in bipolar patients and its relation to prior history of disorder.Am J Psychiatry 1997,154:856–857.
Hlastala SA, Frank E, Kowalski J,et al.:Stressful life events, bipolar disorder, and the “kindling model”.J Abnorm Psychol 2000,109:777–786.
Kraepelin E:Manic-depressive Insanity and Paranoia. Edinburgh: ES Livingstone; 1921.
Cutler NR, Post RM:Life course of illness in untreated manic-depressive patients.Compr Psychiatry 1982,23:101–115.
Ghaemi SN, Boiman EE, Goodwin FK:Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder.Biol Psychiatry 1999,45:137–144.
Grof P, Angst J, Haines T:The clinical course of depression: Practical issues. InClassification and Prediction of Outcome of Depression/Symposium Schloss Reinhartshausen/Rhein, September 23–26, 1973. Edited by Angst J. Stuttgart: FK Schattauer Verlag; 1974:141–148.
Roy-Byrne P, Post RM, Uhde TW,et al.:The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH.Acta Psychiatr Scand Suppl 1985,71:1–34.
Angst J, Sellaro R:Historical perspectives and natural history of bipolar disorder.Biol Psychiatry 2000,48:445–457.
Turvey CL, Coryell WH, Solomon DA,et al.:Long-term prognosis of bipolar I disorder.Acta Psychiatr Scand 1999,99:110–119.
Kessing LV, Andersen PK, Mortensen PB, Bolwig TG:Recurrence in affective disorder. I. Case register study.Br J Psychiatry 1998,172:23–28.
Kessing LV, Mortensen PB, Bolwig TG:Clinical consequences of sensitisation in affective disorder: a case register study.J Affect Disord 1998,47:41–47.
Kessing LV, Hansen MG, Andersen PK, Angst J:The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders — a life-long perspective.Acta Psychiatr Scand 2004,109:339–344.
Solomon DA, Keller MB, Leon AC,et al.:Multiple recurrences of major depressive disorder.Am J Psychiatry 2000,157:229–233.
Post RM, Weiss SIR:Ziskind-Somerfeld Research Award 1992. Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic.Biol Psychiatry 1992,32:469–484.
Post RM, Weiss SRB:A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.Mol Neurobiol 1996,13:33–60.
Goodwin FK, Jamison KR:Manic-depressive illness. New York: Oxford University Press, 1990.
Kupka RW, Luckenbaugh DA, Post RM,et al.:A comparative study of rapid and non-rapid cycling bipolar disorder using daily mood ratings in 539 outpatients.Am J Psychiatry 2004, in press.
Nolen WA, Luckenbaugh DA, Altshuler LL,et al.:Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.Am J Psychiatry 2004,161:1447–1454.
Post RM, Denicoff KD, Leverich GS,et al.:Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method.J Clin Psychiatry 2003,64:680–690.
Leverich GS, Altshuler LL, Frye MA,et al.:Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.J Clin Psychiatry 2003,64:506–515.
Martinez-Aran A, Vieta E, Colom F,et al.:Neuropsychological performance in depressed and euthymic bipolar patients.Neuropsychobiology 2002,46 Suppl 1:16–21.
Ferrier IN, Stanton BR, Kelly TP, Scott J:Neuropsychological function in euthymic patients with bipolar disorder.Br J Psychiatry 1999,175:246–251.
Butters MA, Whyte EM, Nebes RD,et al.:The nature and determinants of neuropsychological functioning in late-life depression.Arch Gen Psychiatry 2004,61:587–595.
Post RM, Speer AM, Hough CJ, Xing G:Neurobiology of bipolar illness: implications for future study and therapeutics.Ann Clin Psychiatry 2003,15:85–94.
Luby ED, Singareddy RK:Long-term therapy with lithium in a private practice clinic: a naturalistic study.Bipolar Disord 2003,5:62–68.
Grunze H:Lithium in the acute treatment of bipolar disorders-a stocktaking.Eur Arch Psychiatry Clin Neurosci 2003,253:115–119.
Baldessarini RJ, Tondo L, Hennen J:Lithium treatment and suicide risk in major affective disorders: update and new findings.J Clin Psychiatry 2003,64(Suppl 5):44–52.
Ahrens B, Muller-Oerlinghausen B, Schou M,et al.:Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis.J Affect Disord 1995,33:67–75.
Chen G, Zeng WZ, Yuan PX,et al.:The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS.J Neurochem 1999,72:879–882.
Chen RW, Chuang DM:Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity.J Biol Chem 1999,274:6039–6042.
Manji HK, Quiroz JA, Sporn J,et al
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.Biol Psychiatry 2003,53:707–742.
RoweMK, ChuangDM:Lithium neuroprotection: molecular mechanisms and clinical implications.Expert Rev Mol Med 2004,6: in press.
Nibuya M, Morinobu S, Duman RS:Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.J Neurosci 1995,15:7539–7547.
Malberg JE, Eisch AJ, Nestler EJ, Duman RS:Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.J Neurosci 2000,20:9104–9110.
Smith MA, Makino S, Kvetnansky R, Post RM:Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.J Neurosci 1995,15:1768–1777.
Smith MA, Makino S, Altemus M,et al.:Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus.Proc Natl Acad Sci U S A 1995,92:8788–8792.
Duman RS:Synaptic plasticity and mood disorders.Mol Psychiatry 2002,7(Suppl 1):S29-S34.
Sheline YI, Gado MH, Kraemer HC:Untreated depression and hippocampal volume loss.Am J Psychiatry 2003,160:1516–1518.
Egan MF, Kojima M, Callicott JH,et al.:The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.Cell 2003,112:257–269.
Neves-Pereira M, Mundo E, Muglia P,et al.:The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.Am J Hum Genet 2002,71:651–655.
Sklar P, Gabriel SB, McInnis MG,et al.:Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.Mol Psychiatry 2002,7:579–593.
Lohoff FW, Sander T, Gallinat J, Berrettini WH:Conformation of association between the Val66Met variation in the BDNF gene and bipolar disorder.Biol Psychiatry 2004,55:10S.
Rybakowski JK, Borkowska A, Czerski PM,et al.:Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients.Bipolar Disord 2003,5:468–472.
Hariri AR, Goldberg TE, Mattay VS,et al.:Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance.J Neurosci 2003,23:6690–6694.
Geller B, Badner JA, Tillman R,et al.:Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met poly-morphism in children with a prepubertal and early adolescent bipolar disorder phenotype.Am J Psychiatry 2004,161:1698–1700.
He XP, Kotloski R, Nef S,et al.:Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model.Neuron 2004,43:31–42.
Suppes T, Baldessarini RJ, Faedda GL, Tohen M:Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.Arch Gen Psychiatry 1991,48:1082–1088.
Post RM, Leverich GS, Altshuler L, Mikalauskas K:Lithium-discontinuation-induced refractoriness: preliminary observations.Am J Psychiatry 1992,149:1727–1729.
Post RM, Leverich GS, Pazzaglia PJ,et al.:Lithium tolerance and discontinuation as pathways to refractoriness. InLithium in Medicine and Biology. Edited by Birch NJ, Padgham C, Hughes MS. Lancashire, UK: Marius Press; 1993:71–84.
Maj M, Pirozzi R, Magliano L:Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors.Am J Psychiatry 1995,152:1810–1811.
Cavanagh J, Smyth R, Goodwin GM:Relapse into mania or depression following lithium discontinuation: a 7-year follow-up.Acta Psychiatr Scand 2004,109:91–95.
Coryell W, Solomon D, Leon AC,et al.:Lithium discontinuation and subsequent effectiveness.Am J Psychiatry 1998,155:895–898.
Post RM:Neurobiology of seizures and behavioral abnormalities.Epilepsia 2004,45(Suppl 2):5–14.
Malach M, Imperato PJ:Depression and acute myocardial infarction.Prev Cardiol 2004,7:83–90.
Post RM, Speer AM, Leverich GS:Complex combination therapy: the evolution toward rational polypharmacy in lithium-resistant bipolar illness. In50 Years: The Psychopharmacology of Bipolar Ilness. Edited by Akiskal H, Tohen M. London: John Wiley & Sons; 2004: in press.
Post RM, Altshuler LL:Mood disorders: treatment of bipolar disorders. InKaplan & Sadock’s Comprehensive Textbook of Psychiatry, edn 8. Edited by Sadock BJ, Sadock VA. New York: Lippincott Williams & Wilkins; 2004: in press.
Post RM:Practical approaches to polypharmacy in the long-term management of bipolar disorder.Drug Benefit Trends 2004,16:329–342.
Post RM, Speer AM, Obrocea GV, Leverich GS:Acute and prophylactic effects of anticonvulsants in bipolar depression.Clin Neurosci Res 2002,2:228–251.